GlassScriptPhysician profile
Mirza A Baig
NPI 1679868707
$540.92
in general payments reported to CMS, 2019-2025
17 companies · $73.42 in 2025
The $73.42 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $58.57 · 2020: $49.87 · 2022: $23.30 · 2023: $153 · 2024: $183 · 2025: $73.42.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $409.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $409.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $117.81 | 2024 | Watchman Access System |
| Heartflow, INC. | $90.45 | 2023 | Ffrct |
| Eli Lilly and Company | $47.33 | 2019 | |
| Allergan, INC. | $32.86 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $31.61 | 2025 | |
| Aimmune Therapeutics, INC. | $25.62 | 2025 | Zenpep |
| Dexcom, INC. | $24.22 | 2023 | Dexcom G6 Transmitter |
| Fresenius USA Marketing, INC. | $23.30 | 2022 | |
| Scpharmaceuticals INC. | $19.87 | 2023 | |
| Esperion Therapeutics, INC. | $19.80 | 2024 | Nexletol |
| Abbvie INC. | $18.32 | 2023 | Vraylar |
| Amarin Pharma, INC. | $17.01 | 2020 | |
| Sumitomo Pharma America, INC. | $16.19 | 2025 | Gemtesa |
| Novo Nordisk INC | $15.77 | 2024 | |
| Viiv Healthcare Company | $15.50 | 2024 | Apretude |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $14.02 | 2024 | Aptima |
| Glaxosmithkline, LLC. | $11.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mirza Baig listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.